Evidence-Based Medicine Guidelines
Creatine for amyotrophic lateral sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Creatine for Amyotrophic Lateral Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis.
Creatine for amyotrophic lateral sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis. Accessed November 22, 2024.
Creatine for amyotrophic lateral sclerosis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis
Creatine for Amyotrophic Lateral Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Creatine for amyotrophic lateral sclerosis
ID - 457103
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457103/all/Creatine_for_amyotrophic_lateral_sclerosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
